Background and Aims: Acute lung injury(ALI) can trigger persistent lung inflammation and fibrosis through activation of the NLRP3inflammasome and subsequent secretion of mature IL-1β, suggesting that the NLRP3 inflammasome is a potential therapeutic target for ALI, for which new therapeutic approaches are needed. Our present study aims toassess whether pirfenidone, with anti-fibrotic and anti-inflammatory properties, can improve LPS-induced inflammation and fibrosis by inhibiting NLRP3 inflammasome activation.
Background and Aims: Acute lung injury(ALI) can trigger persistent lung inflammation and fibrosis through activation of the NLRP3inflammasome and subsequent secretion of mature IL-1β, suggesting that the NLRP3 inflammasome is a potential therapeutic target for ALI, for which new therapeutic approaches are needed. Our present study aims toassess whether pirfenidone, with anti-fibrotic and anti-inflammatory properties, can improve LPS-induced inflammation and fibrosis by inhibiting NLRP3 inflammasome activation.
Methods: Male C57BL/6 J mice were intratracheally injected with LPS to induce ALI. Mice were administered pirfenidone by oral gavage throughout theentire experimental course. The mouse macrophage cell line (J774 A.1) was incubated with LPS and ATP, with orwithout PFD pre-treatment.
Results: We demonstrated that PFD remarkably ameliorated LPS-induced pulmonary inflammation and fibrosis and reduced IL-1β and TGF-β1 levels in bronchoalveolar lavage fluid(BALF).Pirfenidone substantially reduced NLRP3 and ASC expression and inhibited caspase-1 activation and IL-1βmaturation in lung tissues. In vitro, the experiments revealed that PFD significantly suppressed LPS/ATP-induced production of reactive oxygen species (ROS) and decreased caspase-1 activation and the level of IL-1β inJ774 A.1 cells.
Conclusion:
Taken together, the administration of PFD reduced LPS-induced lung inflammation and fibrosisby blocking NLRP3 inflammasome activation and subsequent IL-1β secretion. These findings indicated that PFDcan down-regulate NLRP3 inflammasome activation and that it may offer a promising therapeutic approach forARDS patients. Methods: Murine iPSCs (miPSCs) were delivered via tail vein injection to male, 8-12 week old wild-type, TREM-1 knock-out (KO), and TREM-2 KO C57BL/6 mice 4 h after intratracheal delivery of LPS. Twenty-four hours later, bronchoalveolar lavage fluid and lungs were collected to perform histology, immunohistochemistry, Western blot, and enzyme-linked immunosorbent assays. Neutrophils were also isolated from bone marrow and subjected to Transwell migration assays.
Results: Relative to wild-type control mice, LPS was found to induce overexpression of TREM-1 and TREM-2 in lung tissue. The TREM-2 KO mice induced TREM-1 hyperexpression, and vice versa. In the TREM-2 KO mice (with hyperexpression of TREM-1), increased severity of LPSinduced ALI, increased neutrophil migration, a greater number of neutrophils in BALF, increased expression of Ly6G (a neutrophil marker) in lung, and a higher ratio of P-p38/p38 in neutrophils were observed. However, following the administration of miPSCs, TREM-1 expression was reduced and both histological signs and neutrophil infiltration in the lungs of ALI mice were attenuated. The ratio of P-p38/p38 and expression of VCAM-1 were higher in whole lung extracts following LPS-induced ALI, and these levels were even higher in LPS-treated TREM-2 KO mice. Conversely, the level of IκB in lung tissue decreased in LPS-induced ALI mice and was restored in TREM-2 KO mice with ALI. ELISAs performed with whole lung extracts detected lower levels of pro-inflammatory cytokines (MIP-2 and TNF-α) following the administration of iPSCs, although this reduction was inhibited in LPS-treated TREM-2 KO mice.
In LPS-induced ALI, iPSCs attenuate the infiltration of neutrophils via a mechanism involving TREM-1 expression and the p38/IκB signaling pathway. Background and Aims: To figure out the value and provide possible methods for improving the accuracy of point-of-care ultrasound in assessing the severity of pulmonary edema by analyzing the relationship between the lung ultrasonographic features and the severity of pulmonary edema.
Methods: ①Oleic acid(OA) induced pulmonary edema model was used. 24 New Zealand rabbits were randomly divided into control group (Physiological saline), mild group(OA 0.04 ml/kg), moderate group(OA 0.08 ml/kg) and severe group(OA 0.12 mL/kg). The number and appearance time of B-line, pH, PaO 2 , PaCO 2 , lung coefficient, wet/dry lung ratio and pathological changes of lung tissue were measured. The ultrasound features scale and severity scale were designed, thus, ultrasound features and severity of pulmonary edema were scored. The correlation between the two scales was analyzed. ②Another six severe group 
